−Removed: Market for Registrant’s Common Equity, Related Stockholder
−Removed: Matters and Issuer Purchases of Equity Securities.
+Added: Market for Registrant’s Common
+Added: Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market for Our Common Stock
−Removed: Our common stock is listed for trading on the
−Removed: NASDAQ Global Select Market, or NASDAQ, under the symbol “GURE”.
−Removed: We have never paid cash dividends on our common
−Removed: Holders of our common stock are entitled to receive dividends, if any, declared and paid from time to time by the Board of Directors
−Removed: out of funds legally available.
−Removed: We intend to retain any earnings for the operation and expansion of our business and do not anticipate
−Removed: paying cash dividends in the foreseeable future.
−Removed: Any future determination as to the payment of cash dividends will depend upon future
−Removed: earnings, results of operations, future expansion of bromine and crude salt business and other, capital requirements, our financial
−Removed: condition and other factors that our Board of Directors may consider.
−Removed: Equity Compensation Plan Information
−Removed: 2019 Incentive Stock Plan
−Removed: On December 18, 2019, the Company’s Annual
−Removed: General Meeting adopted and approved the 2019 Omnibus Equity Incentive Plan of Gulf Resources, Inc.(the”2019 Plan”).
−Removed: the 2019 Plan, the Company has reserved a total of 2,068,398 shares of common stock for issuance as or under awards to be made to the
−Removed: directors, officers, employees and/or consultants of the Company and its subsidiaries.
−Removed: On November 30, 2021, the Company’s Annual
−Removed: General Meeting approved to amend the 2019 Plan to increase the number of shares of common stock authorized for issuance under the plan
−Removed: by 900,000 shares.
−Removed: All shares of common stock under the 2019 Plan,
−Removed: as amended, including shares originally authorized by equity holders and shares remaining for future issuance as of December 31, 2023,
−Removed: have been reserved.
−Removed: Our Equity Compensation Plans
−Removed: The following table provides information as of
−Removed: December 31, 2023 about our equity compensation plans and arrangements.
−Removed: Equity Compensation Plan Information -as of December
−Removed: Plan category
−Removed: Number of securities to
−Removed: be issued upon exercise
−Removed: of outstanding options,
−Removed: warrants and rights
−Removed: Weighted-average
−Removed: exercise price of
−Removed: outstanding options,
−Removed: warrants and rights
−Removed: Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
−Removed: Equity compensation plans approved by security holders
−Removed: Equity compensation plans not approved by security holders
−Removed: Purchases of Equity Securities by the Company
−Removed: and Affiliated Purchasers
+Added: Our common stock is listed for trading on the NASDAQ Global
+Added: Select Market, or NASDAQ, under the symbol “GURE”.
+Added: As of April 10, 2025,
+Added: there were 39 record holders of our common stock.
+Added: Securities Authorized for Issuance Under Equity Compensation
+Added: See “Item 12.
+Added: Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters ” for the aggregate information regarding
+Added: our equity compensation plans in effect on December 31, 2024.
+Added: security holders
+Added: Purchases of Equity Securities by the Company and Affiliated
Recent Sales of Unregistered Securities
+Added: Any previous sales of unregistered securities by the Company
+Added: have been previously disclosed in our reports on Form 10-Q or Form 8-K, as applicable, filed with the SEC.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.